Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...